RK Vats to be new NPPA chairman

Health ministry additional secretary Rakesh Kumar Vats has been appointed as the new chairman of the National Pharmaceutical Pricing Authority (NPPA).

This will be an additional charge for Vats, an Indian Administrative Services official from the 1986 West Bengal cadre.

“The competent authority has approved the assignment of the additional charge of the post of Chairman, National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers to Shri Rakesh Kumar Vats…with immediate effect and until further orders,” said a notification from the appointments committee of the cabinet on Friday.

The appointment comes a month after Bhupendra Singh, the previous NPPA chairman, was transferred to the National Authority of Chemical Weapons Commission long before he finished his tenure at the Indian drug pricing regulator.

The move had sparked allegations from patient activists that industry lobby groups pushed for Singh’s transfer after he had implemented several steps unfavourable to them. This includes using emergency powers under Para 19 of the Drug (Prices Control) Order, 2013, to cap maximum retail prices of knee implants and several medicines that were not under price control.

Industry lobbies have denied this allegation.

  • Related Posts

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy, the online medical platform emphasizes the importance of early prevention and regular health screenings to reduce the risk of diabetes. By encouraging individuals to undergo timely blood sugar tests,…

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    India’s pharmaceutical exporters have been offered a fresh business opportunity to expand their presence in Saudi Arabia, with Riyadh-based Al Hobail Medical Company seeking Indian manufacturing partners for the registration…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi